The 1027(th) target candidate in stroke: Will NADPH oxidase hold up?

As recently reviewed, 1026 neuroprotective drug candidates in stroke research have all failed on their road towards validation and clinical translation, reasons being quality issues in preclinical research and publication bias. Quality control guidelines for preclinical stroke studies have now been...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Radermacher, Kim A, Wingler, Kirstin, Kleikers, Pamela, Altenhöfer, Sebastian, JR Hermans, Johannes, Kleinschnitz, Christoph, HHW Schmidt, Harald
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2012
Assuntos:
Review
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3403875/
https://ncbi.nlm.nih.gov/pubmed/22625431
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2040-7378-4-11
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares